Overview
Apheris AI is a Berlin-based deep tech company that builds federated computing infrastructure enabling life sciences organizations to collaborate on sensitive, proprietary data without centralizing it. By keeping data within each organization's own secure environment while enabling joint AI model training and analytics, Apheris addresses one of the most significant barriers to AI in drug discovery: the inability to share patient data, genomic information, and compound libraries across institutional boundaries.
The company's core technology -- federated learning -- allows AI models to travel to the data rather than requiring data to travel to the models. This approach enables pharmaceutical companies, hospitals, and research institutions to pool their AI insights while each participant retains full control of their proprietary datasets. Apheris has found strong product-market fit in life sciences, powering multiple cross-institutional data networks including the AI Structural Biology (AISB) Network, the ADMET Network, and the Antibody Developability Network. The company reports multiplying its revenue by four times since launching its current product in late 2023.
In January 2025, Apheris raised a EUR 20.1 million Series A round co-led by OTB Ventures and eCAPITAL, with participation from existing investors Octopus Ventures and Heal Capital. While the company primarily serves pharmaceutical R&D, its federated data collaboration technology has documented applications in financial services and insurance, where carriers can evaluate external data and models under strict infosec and legal constraints without exposing proprietary datasets.
Products & Services
Apheris Gateway
Core federated computing platform enabling organizations to query, analyze, and train AI models on distributed data without moving or exposing underlying datasets. The Gateway is deployed within each participant's own secure infrastructure, allowing model training and analytics without data egress.
Key Features
- Secure local inference so data, queries, and outputs remain in-house
- Fine-tuning capabilities for proprietary datasets using parameter-efficient methods (LoRA and FRA-LoRA)
- Benchmarking against internal datasets
- GUI and API access to industry-trained models
Target Users: Pharmaceutical companies, research institutions, and enterprise data teams requiring compliant cross-institutional AI collaboration
ApherisFold
Enterprise application for protein structure prediction using co-folding models deployed securely within a company's own IT environment. Supports OpenFold3, Boltz-2, and Protenix-v1. A free Lite version is available for browser-based exploration without infrastructure setup.
Key Features
- Run, benchmark, and fine-tune state-of-the-art co-folding models (OpenFold3, Boltz-2, Protenix-v1)
- Monomer and multi-chain structure prediction, protein-ligand complex modeling, and binding affinity estimation
- Interactive 3D visualization for scientific review
- API access for integration into existing drug discovery pipelines
- Secure local execution -- all data remains within enterprise environment
- Auditable, reproducible records for regulated environments
Target Users: Computational chemists, structural bioinformaticians, and medicinal chemists in pharmaceutical and biotech organizations
Federated Data Networks
Industry-specific collaborative networks powered by the Apheris platform, enabling multiple organizations to jointly train AI models on pooled data without exposing proprietary datasets.
Key Features
- Pre-competitive data sharing without IP exposure
- Network-wide model improvement as more organizations participate
- Governance framework for data access and usage
Target Users: Pharmaceutical companies, biotech firms, and research consortia seeking collaborative AI model development
At a Glance
- Founded
- 2019
- Headquarters
- Berlin, Germany
- Employees
- 51-200
- Funding
- Series A
Category & Focus
- Category
- Federated AI and Secure Data Collaboration
- Subcategories
- Federated learning privacy-preserving machine learning cross-institutional AI model training
- Insurance Verticals
- P&C Life & Annuity (secondary/adjacent use cases)
- Target Customers
- Carriers, Solution Providers
Customers
- AbbVie (AISB Network)
- AstraZeneca (AISB Network)
- Boehringer Ingelheim (AISB Network)
- Bristol Myers Squibb (AISB Network)
- Genentech (AISB Network)
- Johnson & Johnson (AISB Network)
- Sanofi (AISB Network)
- Takeda (AISB Network)
- Astex Pharmaceuticals (AISB Network / Federated OpenFold3)
- Lundbeck (ADMET Network)
- Orion Pharma (ADMET Network)
- Recursion (ADMET Network)
- Servier (ADMET Network)
Similar Companies
-
ePayPolicyDigital payment processing and AR/AP automation built exclusively for the insurance industry. -
DataArt - Finance & InsuranceGlobal software engineering firm delivering custom insurance technology for carriers, reinsurers, and MGAs worldwide. -
DAISNo-code, API-driven digital insurance platform for carriers, MGAs, and brokers to create, distribute, and administer insurance products without software development. -
CSG FORTEUnified payments platform processing USD 118 billion annually for 114,000+ merchants across insurance, government, healthcare, and utilities. -
COVIEAPI infrastructure for real-time insurance data access -- the connectivity layer between applications and insurance carriers. -
CCOVER DESKDedicated virtual assistant services for insurance agencies, MGAs, and carriers.
Last updated: 2026-04-04